Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Caramaschi P et al. - While the development of antinuclear and, less frequently, of anti-DNA antibodies is a common finding, the onset of autoimmune diseases during anti-TNFalpha blocker treatment is a rare event, which needs to be promptly recognized in order to plan the appropriate management. Moreover the specific autoantibodies associated with rheumatoid arthritis are considered before and after biotherapy.

   

Today in Clinical Pharmacology...keeping you current

Treatment with the PPAR-gamma agonist rosiglitazone down-regulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
European Journal of Endocrinology, 11/24/09

Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis
Expert Review of Clinical Immunology, 11/23/09

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09

Today in Rheumatic/Autoimmune...keeping you current

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09

Adalimumab for the treatment of psoriatic arthritis
Expert Review of Clinical Immunology, 11/19/09

Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
BMC Musculoskeletal Disorders, 11/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address